Otros idiomas Longboard Pharmaceuticals, Inc.

Acciones

LBPH

US54300N1037

Tiempo real estimado Cboe BZX Otros sitios de cotización 19:18:13 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
21,12 ^USD	-0,49 %		+3,48 %	+247,84 %

12/03	Longboard Pharmaceuticals, Inc. informa de los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI
16/01	LONGBOARD PHARMACEUTICALS, INC. : recomendación de compra de Cantor Fitzgerald	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	03/04
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15	03/04
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02/04
Longboard Pharmaceuticals, Inc. announced that it has received $59.85 million in funding	26/03
Longboard Pharmaceuticals, Inc.(NasdaqGM:LBPH) added to S&P Pharmaceuticals Select Industry Index	18/03
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates	12/03
LONGBOARD PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	04/03
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	01/03
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	02/02
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February	01/02
LONGBOARD PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK AND FULL EXERCISE OF UNDERWRITERS OPTION TO PURCHASE ADDITIONAL SHARES	09/01
Longboard Pharmaceuticals Closes $242 Million Public Offering	08/01
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	08/01
Longboard Pharmaceuticals Prices $210 Million Stock Offering	04/01
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock	04/01
LONGBOARD PHARMACEUTICALS ANNOUNCES POSITIVE TOPLINE DATA FROM THE PACIFIC STUDY, A PHASE 1B/2A CLINICAL TRIAL, FOR BEXICASERIN IN PARTICIPANTS WITH DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES	03/01
Longboard Pharmaceuticals Launching Share Offering	02/01
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock	02/01
Sector Update: Health Care Stocks Gain Late Afternoon	02/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Longboard Pharmaceuticals, Inc.

Acciones

LBPH

US54300N1037

Otros idiomas

Filtros